AstraZeneca Shares Slide 7% on Bristol Myers Merger Talks Reports

SentiSense · Published · Updated

AstraZeneca's shares fell 7% due to reports of potential merger talks with Bristol Myers Squibb. The stock's decline affected the FTSE 100 index. Vari...

Sign in to read the full story. Free accounts include 20 full reads a month.

Sign in or create a free account

Powered by SentiSense - Intelligent Market Analysis